HERCEPTIN
Herceptin (Trastuzumab) is an FDA-approved monoclonal antibody infusion therapy used for the treatment of HER2-positive breast cancer, metastatic gastric cancer, and other HER2-overexpressing malignancies in adult patients. Each 1×1 EA powder vial contains Trastuzumab, formulated for intravenous administration after reconstitution under professional supervision.
Trastuzumab works by targeting the HER2 receptor, which is overexpressed on certain cancer cells, helping to inhibit tumor cell proliferation, induce antibody-dependent cytotoxicity, and improve overall treatment outcomes. It is commonly used alone or in combination with chemotherapy as part of a comprehensive cancer treatment plan.
InfusionMed USA, based in Carrollton, Texas, supplies Herceptin and other specialty oncology infusion therapies to hospitals, clinics, and infusion centers across Dallas, McKinney, Frisco, Plano, Lewisville, The Colony, and surrounding North Texas areas. We ensure cold-chain compliance, proper handling, and timely delivery for licensed healthcare providers.
For professional use only.
Download Form